BIOMET INC
S-8, 1998-10-01
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Previous: HEI INC, 8-K, 1998-10-01
Next: FRANKLIN TAX EXEMPT MONEY FUND, 497, 1998-10-01



                                                  Registration No. ___________	


                        SECURITIES AND EXCHANGE COMMISSION
                             Washington, D. C. 20549           

                                    FORM S-8
             REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933     

                                  Biomet, Inc.
              (Exact name of registrant as specified in its charter)

                  Indiana                             35-1418342    
          (State or other jurisdiction of          (I.R.S. Employer
           incorporation or organization)					    Identification No.)

                            Post Office Box 587
                          Airport Industrial Park
                         Warsaw, Indiana 46581-0587	                     
                (Address of Principal Executive Offices)

        1998 Biomet, Inc. Qualified and Non-Qualified Stock Option Plan 
                          (Full title of the plan)

           		Daniel P. Hann, Vice President and General Counsel
                               Biomet, Inc.
                            Post Office Box 587
                          Airport Industrial Park
                         Warsaw, Indiana 46581-0587         
                   (Name and address of agent for service)

                               (219) 372-1539
        (Telephone number, including area code, of agent for service)
 
                               Copies to:
                             Berkley W. Duck
                        Ice Miller Donadio & Ryan
                      One American Square, Box 82001
                        Indianapolis, Indiana 46282

CALCULATION OF REGISTRATION FEE
________________________________________________________________________________
                                    Proposed          Proposed
                                    maximum           maximum 
Title of          Amount            offering          aggregrate     Amount
securities to     to be             price             offering       of regis-
be registered     registered        per unit          price(1)       tration fee
________________________________________________________________________________

Common Shares     7,000,000 shares  $33.75            $236,250,000   $69,693.75
________________________________________________________________________________

 (1) The registration fee has been calculated pursuant to Rule 457(c) and (h)
based upon the average of the high and low prices reported for the Common Shares
on September 25, 1998.

PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 3.  Incorporation of Documents by Reference.

The following information heretofore filed with the Securities and Exchange 
Commission ("Commission") pursuant to the Securities Exchange Act of 1934, as 
amended (the "Exchange Act"), is incorporated herein by reference:

(a) The latest Annual Report on Form 10-K of Biomet, Inc. (the "Registrant"). 

(b) All other reports filed by the Registrant pursuant to Section 13(a) or 15(d)
of the Exchange Act since the end of the fiscal year covered by the Annual 
Report referred to in (a) above. 

(c) The information set forth under the caption "Description of Registrant's 
Securities to be Registered" in the Registrant's Registration on Form 8-A filed 
pursuant to Section 12(g) of the Exchange Act, dated September 9, 1983, 
Registration No. 0-12515, including any amendments or reports filed for the 
purpose of updating that description.

All documents filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and
15(d) of the Exchange Act subsequent to the filing of this Registration 
Statement and prior to the filing of a post-effective amendment, which indicates
that all of the securities offered hereby have been sold or which deregisters 
all such securities then remaining unsold, shall be deemed to be incorporated by
reference in this Registration Statement and to be a part hereof from the date 
of filing of those documents.  

Item 4.  Description of Securities.

Not applicable.

Item 5.  Interests of Named Experts and Counsel.

Not applicable.

Item 6.  Indemnification of Directors and Officers.

The Indiana Business Corporation Law ("IBCL"), the provisions of which govern 
the Registrant, empowers an Indiana corporation to indemnify present and former 
directors, officers, employees, or agents or any person who may have served at 
the request of the corporation as a director, officer, employee, or agent of 
another corporation ("Eligible Persons") against liability incurred in any 
proceeding, civil or criminal, in which the Eligible Person is made a party by 
reason of being or having been in any such capacity, or arising out of his 
status as such, if the individual acted in good faith and reasonably believed
that (a) the individual was acting in the best interests of the corporation, 
or (b) if the challenged action was taken other than in the individual's 
official capacity as an officer, director, employee or agent, the individual's 
conduct was at least not opposed to the corporation's best interests, or (c) if 
in a criminal proceeding, either the individual had reasonable cause to believe 
his conduct was lawful or no reasonable cause to believe his conduct was 
unlawful.

The IBCL further empowers a corporation to pay or reimburse the reasonable 
expenses incurred by an Eligible Person in connection with the defense of any 
such claim, including counsel fees; and, unless limited by its Articles of 
Incorporation, the corporation is required to indemnify an Eligible Person 
against reasonable expenses if he is wholly successful in any such proceeding, 
on the merits or otherwise.  Under certain circumstances, a corporation may pay 
or reimburse an Eligible Person for reasonable expenses prior to final 
disposition of the matter.  Unless a corporation's articles of incorporation 
otherwise provide, an Eligible Person may apply for indemnification to a court 
which may order indemnification upon a determination that the Eligible Person is
entitled to mandatory indemnification for reasonable expenses or that the 
Eligible Person is fairly and reasonably entitled to indemnification in view 
of all the relevant circumstances without regard to whether his actions 
satisfied the appropriate standard of conduct.

Before a corporation may indemnify any Eligible Person against liability or 
reasonable expenses under the IBCL, a quorum consisting of directors who are 
not parties to the proceeding must (1) determine that indemnification is 
permissible in the specific circumstances because the Eligible Person met the 
requisite standard of conduct, (2) authorize the corporation to indemnify the 
Eligible Person and (3) if appropriate, evaluate the reasonableness of expenses 
for which indemnification is sought.  If it is not possible to obtain a quorum 
of uninvolved directors, the foregoing action may be taken by a committee of two
or more directors who are not parties to the proceeding, special legal counsel 
selected by the Board or such a committee, or by the shareholders of the 
corporation.

In addition to the foregoing, the IBCL states that the indemnification it 
provides shall not be deemed exclusive of any other rights to which those 
indemnified may be entitled under any provision of the articles of incorporation
or bylaws, resolution of the board of directors or shareholders, or any other 
authorization adopted after notice by a majority vote of all the voting shares 
then issued and outstanding.  The IBCL also empowers an Indiana corporation to 
purchase and maintain insurance on behalf of any Eligible Person against any 
liability asserted against or incurred by him in any capacity as such, or 
arising out of his status as such, whether or not the corporation would have 
had the power to indemnify him against such liability.

Section 9.3 of Article IX of the Amended Articles of Incorporation and Article 
VII of the Amended and Restated Bylaws of Biomet, Inc. provide certain 
indemnification provisions for the benefit of directors, officers, employees 
and agents of the Registrant.

The Registrant has obtained directors' and officers' liability insurance, the 
effect of which is to indemnify the directors and officers of Biomet, Inc. and 
its subsidiaries against certain losses caused by errors, misleading statements,
wrongful acts, omissions, neglect or breach of duty by them or any matter 
claimed against them in their capacities as directors and officers.


Item 7.  Exemption From Registration Claimed.

Not applicable.

Item 8.  Exhibits.

See Index to Exhibits.

Item 9.  Undertakings.

The undersigned Registrant hereby undertakes:

(1) To file, during any period in which offers or sales are being made, a post-
effective amendment to this Registration Statement:

  (i)   To include any prospectus required by section 10(a)(3) of 
        the Securities Act of 1933, as amended (the "Securities Act");
  (ii)  To reflect in the prospectus any facts or events arising after the
        effective date of the Registration Statement (or the most recent post-
        effective amendment thereof) which, individually or in the aggregate, 
        represent a fundamental change in the information set forth in the 
        Registration Statement;
  (iii) To include any material information with respect to the plan of
        distribution not previously disclosed in the Registration Statement or 
        any material change to such information in the Registration Statement.

Provided, however, that paragraphs (1)(i) and (1)(ii) shall not apply if the 
information required to be included in a post-effective amendment by those 
paragraphs is contained in periodic reports filed with or furnished to the 
Commission by the Registrant pursuant to Section 13 or Section 15(d) of the 
Exchange Act that are incorporated by reference in the Registration Statement.

(2) That for the purpose of determining any liability under the Securities Act, 
each such post-effective amendment shall be deemed to be a new registration 
statement relating to the securities offered therein, and the offering of such 
securities at that time shall be deemed to be the initial bona fide offering 
thereof.

(3) To remove from registration by means of a post-effective amendment any of 
the securities being registered which remain unsold at the termination of the 
offering.

(4) That, for purposes of determining any liability under the Securities Act, 
each filing of the Registrant's annual report pursuant to Section 13(a) or 
Section 15(d) of the Exchange Act (and, where applicable, each filing of an 
employee benefit plan's annual report pursuant to Section 15(d) of the Exchange 
Act) that is incorporated by reference in the Registration Statement shall be 
deemed to be a new registration statement relating to the securities offered 
therein, and the offering of such securities at that time shall be deemed to be 
the initial bona fide offering thereof.

Insofar as indemnification for liabilities arising under the Securities Act may 
be permitted to directors, officers and controlling persons of the Registrant 
pursuant to the foregoing provisions, or otherwise, the Registrant has been 
advised that in the opinion of the Commission such indemnification is against 
public policy as expressed in the Securities Act and is, therefore, 
unenforceable.  In the event that a claim for indemnification against such 
liabilities (other than the payment by the Registrant of expenses incurred or 
paid by a director, officer or controlling person of the Registrant in the 
successful defense of any action, suit or proceeding) is asserted by such 
director, officer or controlling person in connection with the securities being 
registered, the Registrant will, unless in the opinion of its counsel the matter
has been settled by controlling precedent, submit to a court of appropriate 
jurisdiction the question whether such indemnification by it is against public 
policy as expressed in the Securities Act and will be governed by the final 
adjudication of such issue.


SIGNATURES

Pursuant to the requirements of the Securities Act, the Registrant certifies 
that it has reasonable grounds to believe that it meets all of the requirements 
for filing on Form S-8 and has duly caused this Registration Statement to be 
signed on its behalf by the undersigned, thereunto duly authorized, in the City 
of Warsaw, State of Indiana, on September 26, 1998.


BIOMET, INC.
					 	
By:  /s/ Daniel P, Hann
     Daniel P. Hann, Vice President 
     and General Counsel


POWER OF ATTORNEY

Know all men by these presents, that each person whose signature appears below 
constitutes and appoints Dane A. Miller, Ph.D. and Daniel P. Hann, and each or 
any of them (with full power to act alone), his or her true and lawful 
attorneys-in-fact and agents with full power of substitution and resubstitution,
for him or her and in his or her name, place and stead, in any and all 
capacities, to sign any and all amendments to this Registration Statement, and 
to file the same, with all exhibits thereto, and other documents in connection 
therewith, with the Securities and Exchange Commission, granting unto those 
attorneys-in-fact and agents full power and authority to do and perform each and
every act and thing requisite and necessary to be done in and about the 
premises, as fully to all intents and purposes as he or she might or could do 
in person, hereby ratifying and confirming all that those attorneys-in-fact and 
agents, or their substitutes, may do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration 
Statement has been signed by the following persons in the capacities indicated 
on September 26, 1998.


/s/ DANE A. MILLER, Ph.D.   President, Chief Executive Officer 
Dane A. Miller, Ph.D.       (Principal Executive Officer) and Director

/s/ GREGORY D. HARTMAN      Vice President-Finance (Principal Financial Officer)
Gregory D. Hartman

/s/ JAMES W. HALLER         Controller (Principal Accounting Officer)
James W. Haller

/s/ JERRY L. FERGUSON       Director
Jerry L. Ferguson

/s/ DANIEL P. HANN          Director
Daniel P. Hann

/s/ C. SCOTT HARRISON       Director
C. Scott Harrison

/s/ M. RAY HARROFF          Director
M. Ray Harroff

/s/ THOMAS F. KEARNS, JR.   Director
Thomas F. Kearns, Jr.

/s/ JERRY L. MILLER         Director
Jerry L. Miller

/s/ KENNETH V. MILLER       Director
Kenneth V. Miller

/s/ CHARLES E. NIEMIER      Director
Charles E. Niemier

/s/ NILES L. NOBLITT        Chairman and Director
Niles L. Noblitt

/s/ MARILYN TUCKER QUAYLE   Director
Marilyn Tucker Quayle

/s/ PROF. DR. BERNHARD SCHEUBLE Director
Prof. Dr. Bernhard Scheuble

/s/ L. GENE TANNER          Director
L. Gene Tanner


BIOMET, INC.
Form S-8	
	
INDEX TO EXHIBITS

Exhibit Number 
Assigned in									
Regulation S-K
Item 601          Description of Exhibit

(4)   4.1      Specimen Certificate for Common Shares of the Company. 		
               (Incorporated by reference to Exhibit 4.1 to the Registrant's		
               Report on Form 10-K for the fiscal year ended May 31, 1985)

      4.2      Rights Agreement between Biomet, Inc. and Lake City Bank, as	
               Rights Agent, dated as of December 2, 1989.  (Incorporated by	
               reference to Exhibit 4 to Biomet, Inc. Form 8-K Current Report	
               dated December 22, 1989, File No. 0-12515.)

(5)   5.1      Opinion of Ice Miller Donadio & Ryan		  
			
(15)           Not Applicable		
			
(23) 23.1      Consent of PricewaterhouseCoopers LLP  
			
     23.2      Consent of Ice Miller Donadio & Ryan (Included in Exhibit 5.1)	

(24)           Power of Attorney (See Signature Page)
			
(28)           Not Applicable	


EXHIBIT 5.1

September 29, 1998	

Board of Directors
Biomet, Inc.
Post Office Box 587
Airport Industrial Park
Warsaw, IN 46581-0587

Ladies and Gentlemen:

We have acted as counsel to Biomet, Inc., an Indiana corporation (the 
"Company"), in connection with the filing of a Registration Statement on Form 
S-8 (the "Registration Statement"), with the Securities and Exchange Commission 
(the "Commission") for the purposes of registering under the Securities Act of 
1933, as amended (the "Securities Act"), 7,000,000 of the Company's authorized 
but unissued Common Shares  (the "Common Shares") issuable under the 1998 
Biomet, Inc. Qualified and Non-Qualified Stock Option Plan (the "Plan").

In connection therewith, we have investigated those questions of law as we have 
deemed necessary or appropriate for purposes of this opinion.  We have also 
examined originals, or copies certified or otherwise identified to our 
satisfaction, of those documents, corporate or other records, certificates and 
other papers that we deemed necessary to examine for purposes of this opinion, 
including:

 1. The Company's Articles of Incorporation, together with all amendments 
    thereto;

 2. The Bylaws of the Company, as amended to date;

 3. Resolutions relating to the Plan and the Common Shares adopted by the 
    Company's Board of Directors (the "Resolutions");

 4. A specimen certificate representing the Common Shares;

 5. The Registration Statement; and

 6. The Plan.

We have also relied, without investigation as to the accuracy thereof, on other 
certificates of, and oral and written communications from, public officials and 
officers of the Company.

For purposes of this opinion, we have assumed (i) the genuineness of all 
signatures of all parties other than the Company; (ii) the authenticity of all 
documents submitted to us as originals and the conformity to authentic originals
of all documents submitted to us as certified or photostatic copies; (iii) that
the Common Shares will be issued pursuant to the terms of the Registration 
Statement; (iv) that the Resolutions will not be amended, altered or superseded 
prior to the issuance of the Common Shares; and (v) that no changes will occur 
in the applicable law or the pertinent facts prior to the issuance of the Common
Shares.

Based upon the foregoing and subject to the qualifications set forth in this 
letter, we are of the opinion that the Common Shares to be issued pursuant to 
the terms of the Plan are validly authorized and, when (a) the pertinent 
provisions of the Securities Act and all relevant state securities laws have 
been complied with and (b) the Common Shares have been delivered against payment
therefor as contemplated by the Registration Statement and the Plan, the Common 
Shares will be legally issued, fully paid and non-assessable.

We hereby consent to the filing of this opinion as an exhibit to the 
Registration Statement.  In giving this consent, we do not admit that we are 
within the category of persons whose consent is required under Section 7 of the 
Securities Act or under the rules and regulations of the Commission relating 
thereto.


Very truly yours,

/S/
 
ICE MILLER DONADIO & RYAN	


EXHIBIT 23.1

CONSENT OF INDEPENDENT ACCOUNTANT

We consent to the incorporation by reference in this registration statement of 
Biomet, Inc. on Form S-8 of our reports dated July 2, 1998, on our audits of the
consolidated financial statements and financial statement schedule of Biomet, 
Inc. and subsidiaries at May 31, 1998 and 1997, and for each of the three years 
in the period ended May 31, 1998, which reports are included in the Biomet, Inc.
Annual Report of Form 10-K for the year ended May 31, 1998.

/s/
PricewaterhouseCoopers LLP

South Bend, Indiana
September 25, 1998



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission